CN110430872A - 治疗痤疮的组合物 - Google Patents

治疗痤疮的组合物 Download PDF

Info

Publication number
CN110430872A
CN110430872A CN201880019063.8A CN201880019063A CN110430872A CN 110430872 A CN110430872 A CN 110430872A CN 201880019063 A CN201880019063 A CN 201880019063A CN 110430872 A CN110430872 A CN 110430872A
Authority
CN
China
Prior art keywords
solvent
ethanol
ethoxyethoxy
pharmaceutical composition
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201880019063.8A
Other languages
English (en)
Chinese (zh)
Inventor
E.库珀
M.卡拉汉
M.特恩
D.迪卡森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Botanix Pharmaceuticals Ltd
Original Assignee
Botanix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900498A external-priority patent/AU2017900498A0/en
Application filed by Botanix Pharmaceuticals Ltd filed Critical Botanix Pharmaceuticals Ltd
Priority claimed from PCT/AU2018/050117 external-priority patent/WO2018148795A1/en
Publication of CN110430872A publication Critical patent/CN110430872A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201880019063.8A 2017-02-15 2018-02-14 治疗痤疮的组合物 Pending CN110430872A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762459312P 2017-02-15 2017-02-15
AU2017900498 2017-02-15
AU2017900498A AU2017900498A0 (en) 2017-02-15 Compositions for Treating Acne
US62/459,312 2017-02-15
PCT/AU2018/050117 WO2018148795A1 (en) 2017-02-15 2018-02-14 Compositions for treating acne

Publications (1)

Publication Number Publication Date
CN110430872A true CN110430872A (zh) 2019-11-08

Family

ID=67766788

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880019063.8A Pending CN110430872A (zh) 2017-02-15 2018-02-14 治疗痤疮的组合物

Country Status (8)

Country Link
US (2) US20200022927A1 (cg-RX-API-DMAC7.html)
EP (1) EP3582763A4 (cg-RX-API-DMAC7.html)
JP (1) JP2020508993A (cg-RX-API-DMAC7.html)
CN (1) CN110430872A (cg-RX-API-DMAC7.html)
AU (1) AU2018221889A1 (cg-RX-API-DMAC7.html)
BR (1) BR112019017045A2 (cg-RX-API-DMAC7.html)
CA (1) CA3053507A1 (cg-RX-API-DMAC7.html)
IL (1) IL268715A (cg-RX-API-DMAC7.html)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067887A2 (en) * 2001-02-26 2002-09-06 Dicianna Valerie Dumont Self-tanning composition in sheeted substrate
US20070135379A1 (en) * 2004-03-22 2007-06-14 Galderma Research & Development Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
US20100261795A1 (en) * 2009-04-08 2010-10-14 Pierre Fabre Dermocosmetique Usa Antiacneic compositions
WO2012097264A2 (en) * 2011-01-13 2012-07-19 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
WO2014066225A1 (en) * 2012-10-24 2014-05-01 Kulesza John E Low toxicity topical active agent delivery system
US20140142184A1 (en) * 2012-11-20 2014-05-22 Allergan, Inc. Topical dapsone and dapsone/adaplene compositions and methods for use thereof
WO2014116653A1 (en) * 2013-01-22 2014-07-31 Coty Inc. Topical formulations and methods for the use thereof
US20150118164A1 (en) * 2007-12-07 2015-04-30 Foamix Pharmaceuticals Ltd. Oil and Liquid Silicone Foamable Carriers and Formulations
WO2015063723A1 (en) * 2013-10-31 2015-05-07 Ranbaxy Laboratories Limited Topical pharmaceutical composition of acitretin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6093007B2 (ja) * 2012-04-27 2017-03-08 ダウ コーニング コーポレーションＤｏｗ Ｃｏｒｎｉｎｇ Ｃｏｒｐｏｒａｔｉｏｎ 基質に有効成分を送達するためのシリコーン系賦形剤を含有する局所用製剤組成物

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067887A2 (en) * 2001-02-26 2002-09-06 Dicianna Valerie Dumont Self-tanning composition in sheeted substrate
US20070135379A1 (en) * 2004-03-22 2007-06-14 Galderma Research & Development Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle
US20150118164A1 (en) * 2007-12-07 2015-04-30 Foamix Pharmaceuticals Ltd. Oil and Liquid Silicone Foamable Carriers and Formulations
US20100261795A1 (en) * 2009-04-08 2010-10-14 Pierre Fabre Dermocosmetique Usa Antiacneic compositions
WO2012097264A2 (en) * 2011-01-13 2012-07-19 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
WO2014066225A1 (en) * 2012-10-24 2014-05-01 Kulesza John E Low toxicity topical active agent delivery system
US20140142184A1 (en) * 2012-11-20 2014-05-22 Allergan, Inc. Topical dapsone and dapsone/adaplene compositions and methods for use thereof
WO2014116653A1 (en) * 2013-01-22 2014-07-31 Coty Inc. Topical formulations and methods for the use thereof
WO2015063723A1 (en) * 2013-10-31 2015-05-07 Ranbaxy Laboratories Limited Topical pharmaceutical composition of acitretin

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DAVID W OSBORNE: "Diethylene glycol monoethyl ether: an emerging solvent in topical dermatology products", 《JOURNAL OF COSMETIC DERMATOLOGY》 *
SCIENTIFIC COMMITEE ON CONSUMER SAFETY: "Opinion on diethylene glycol monoethyl ether (DEGEE)", 《EUROPEAN COMMISSION》 *

Also Published As

Publication number Publication date
AU2018221889A1 (en) 2019-09-05
US20200022927A1 (en) 2020-01-23
EP3582763A1 (en) 2019-12-25
JP2020508993A (ja) 2020-03-26
IL268715A (en) 2019-10-31
BR112019017045A2 (pt) 2020-04-14
CA3053507A1 (en) 2018-08-23
EP3582763A4 (en) 2020-11-25
US20220331269A1 (en) 2022-10-20

Similar Documents

Publication Publication Date Title
RU2429815C2 (ru) Безводная многофазная гелевая система
US7740875B2 (en) Organo-gel formulations for therapeutic applications
EP2691077B1 (en) Salicylic acid topical formulation
JP2022185150A (ja) ざ瘡の処置のためのカンナビノイドの製剤
JP2017500356A (ja) ポリカプロラクトンポリマーを含む局所用ゲル組成物、及び有益剤の局所適用を増強するための方法
EP1796632A1 (en) Organo-gel formulations for therapeutic applications
JP2017505294A (ja) ポリ（モノステアロイルグリセロール−ｃｏ−スクシネート）ポリマーを含む局所用ゲル組成物、及び有益剤の局所適用を増強するための方法
JP2019524876A (ja) 水可溶化されたウルソデオキシコール酸を含有する炎症性皮膚疾患または重症掻痒症の予防または治療用組成物
JP7012089B2 (ja) 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤
CN102048724A (zh) 用于治疗皮肤的过氧化苯甲酰组合物
WO2018148786A1 (en) Formulations of cannabinoids for the treatment of acne
US20110236503A1 (en) Topical Skincare Composition
EP2563357A1 (en) Method for treating scars with adapalene 0.3%
JP5667052B2 (ja) ダナゾールを含む経真皮医薬組成物
CN1972708A (zh) 用于局部治疗的组合物
BRPI0617045A2 (pt) composição, processo para preparar uma composição, uso de uma composição e uso cosmético de uma composição
CN110430872A (zh) 治疗痤疮的组合物
WO2018148795A1 (en) Compositions for treating acne
CN110520123A (zh) 用于治疗银屑病的大麻素制剂
JPH0446B2 (cg-RX-API-DMAC7.html)
BR112016014612B1 (pt) Composições tópicas em gel incluindo polímero de policaprolactona e métodos para aprimorar a aplicação tópica de um agente de benefício

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20191108

WD01 Invention patent application deemed withdrawn after publication